Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal antibiotic regimen after endoscopic treatment of gastroesophageal varices in cirrhosis
ChiCTR2200059456Phase 4Recruiting
- Sponsor
- Beijing YouAn Hospital
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Gastroesophageal varices (GEV) and Cirrhosis comparing cefuroxime prophylaxis with cefotaxime + sulbactam prophylaxis (2 arms). Primary endpoints: whole blood cell analysis and procalcitonin (PCT). Started Jan 2022; status: recruiting.
02
Drugs
cefuroximecefotaximesulbactam
03
Conditions
Gastroesophageal varices (GEV)Cirrhosis
Beyond the preview
Go deeper on ChiCTR2200059456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200059456.